Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
The compositions and methods of administration described in this invention are based on indole carbazole, which causes terminal differentiation of tumor cells by exploiting a normal physiologic pathway. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Jun 2011 - 58 pages - $500
Dec 2010 - 54 pages - $1,000
Feb 2011 - 6 pages - $500
May 2011 - 7 pages - $500
Dec 2010 - 27 pages - $500
Jul 2011 - 390 pages - $500
Mar 2011 - 29 pages - $3,800
Feb 2010 - 138 pages - $2,265
Dec 2010 - 75 pages - $1,000
Dec 2010 - 73 pages - $1,000
Your selection
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us